EU moves toward web portals for adverse events

The European Parliament has signed off on the Pharmacovigilance directive, which would require national governments to set up medicine web portals containing information on drug products and side effects. Instructions for reporting suspected adverse reactions would also be included. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.